Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands. With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality. Solaris Pharma Corporation is currently engaged in the development of several generic dermatology products and is committed to establish itself as a pacesetter in dermatology pharmaceuticals.